Teva Pharmaceutical Industries Limited (NYSE:TEVA) Q3 2022 Earnings Conference Call November 3, 2022 8:00 AM ET

Company Participants

Ran Meir - Senior Vice President, Head of Investor Relations

Kare Schultz - President and Chief Executive Officer

Eli Kalif - Executive Vice President and Chief Financial Officer

Sven Dethlefs - Executive Vice President, North America Commercial

Conference Call Participants

Elliot Wilbur - Raymond James

Glen Santangelo - Jefferies

Umer Raffat - Evercore

Jason Gerberry - Bank of America

Denis Reznik - BMO Capital Markets

Ashwani Verma - UBS

David Amsellem - Piper Sandler

Operator

Good day and thank you for standing by. Welcome to the Teva's Third Quarter 2022 Financial Results Conference Call. At this time all participants are in listen-only mode. After the speakers' presentation, there will be a question-and-answer session. [Operator instructions] Please be advised that today's conference is being recorded.

I would now like to hand the conference over to your first speaker today, Ran Meir, Senior Vice President, Head of Investor Relations.

Ran Meir

Thank you, Nadia. Thank you, everyone, for joining us today to discuss Teva's third quarter 2022 financial results. We hope you have had an opportunity to review our earnings press release, which was issued earlier this morning. A copy of this press release, as well as a copy of the slides being presented on this call can be found on our website at tevapharm.com.

Please review our forward-looking statements on Slide number 2. Additional information regarding these statements and our non-GAAP financial measures is available on our earnings release and in our SEC Forms, 10-K and 10-Q.

To begin today's call, Kare Schultz, Teva's CEO will provide an overview of the third quarter performance, recent events and priorities going forward. Our CFO Eli Kalif will follow up by reviewing the financial results in more detail, including our 2022 financial outlook. Joining Kare and Eli on the call today is Sven Dethlefs, Teva's Head of North America business who will be available during the question and answer session that will follow the presentation. Please note that today's call will run approximately one hour.

And with that, I will now turn the call over to Kare. Kare, if you would please?

Kare Schultz

Thank you, Ran and welcome to all of you. Let's take a look at the highlights for the third quarter. We came in with revenues of $3.6 billion and our adjusted EBITDA came in at US$1.1 billion. The GAAP diluted earnings per share were $0.05 and the non-GAAP diluted earnings per share were $0.59.